Windtree converts Series C Preferred to common at $0.1608, issuers 11.8M shares; holders grant forbearance.

WINDTREE THERAPEUTICS INC /DE/

Approximately 1,895 Series C Preferred shares converted into 11,792,305 common shares at reduced conversion price of $0.1608.
Holders agreed to forbearance on claims under securities purchase agreements and warrants through April 30, 2025.
Exercise price of related warrants also reduced to $0.1608 effective January 24, 2025.
Conversion was effected via a Conversion Notice signed by holders by Jan 31, 2025; exempt from registration under Section 3(a)(9) and 4(a)(2).
Company had previously registered up to 27,668,106 shares for resale on Form S-3 effective Sep 3, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.